BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 16338206)

  • 41. Ineffectiveness of rat liver tissues in the screening of connective tissue disease.
    Aziz KA
    Saudi Med J; 2004 Apr; 25(4):442-6. PubMed ID: 15083212
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Evaluation of simultaneous detection of specific antinuclear antibodies using multiplexed technology].
    Uto K; Hayashi N; Kinoshita S; Kawano S; Kumagai S
    Rinsho Byori; 2009 Oct; 57(10):941-53. PubMed ID: 19928490
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical use of anti-DFS70 autoantibodies.
    Kang SY; Lee WI; Kim MH; La Jeon Y
    Rheumatol Int; 2019 Aug; 39(8):1423-1429. PubMed ID: 30972541
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Significance of extractable nuclear antigens in childhood autoimmune liver disease.
    Gregorio GV; Davies ET; Mieli-Vergani G; Vergani D
    Clin Exp Immunol; 1995 Nov; 102(2):308-13. PubMed ID: 7586683
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Performance of antinuclear antibody connective tissue disease screen.
    López-Hoyos M; Rodríguez-Valverde V; Martinez-Taboada V
    Ann N Y Acad Sci; 2007 Aug; 1109():322-9. PubMed ID: 17785321
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Exploring Systemic Autoimmunity in Thyroid Disease Subjects.
    Siriwardhane T; Krishna K; Ranganathan V; Jayaraman V; Wang T; Bei K; Rajasekaran JJ; Krishnamurthy H
    J Immunol Res; 2018; 2018():6895146. PubMed ID: 30911555
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [An immunoenzymatic technique for the detection of antinuclear antibodies].
    Meriche H; Meriche-Gadiri S; Ghaffor M; Abbadi MC
    Ann Biol Clin (Paris); 2000; 58(6):711-4. PubMed ID: 11098167
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detection and identification of antinuclear antibodies (ANA) in a large community hospital.
    Verstegen G; Duyck MC; Meeus P; Ravelingien I; De Vlam K
    Acta Clin Belg; 2009; 64(4):317-23. PubMed ID: 19810418
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Frequency and Clinical Utility of Antibodies to Extractable Nuclear Antigen in the Setting of a Negative Antinuclear Antibody Test.
    Yeo AL; Ojaimi S; Le S; Leech M; Morand E
    Arthritis Care Res (Hoboken); 2023 Jul; 75(7):1595-1601. PubMed ID: 35904968
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Understanding and interpreting antinuclear antibody tests in systemic rheumatic diseases.
    Bossuyt X; De Langhe E; Borghi MO; Meroni PL
    Nat Rev Rheumatol; 2020 Dec; 16(12):715-726. PubMed ID: 33154583
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of the LIA-ANA-Profile-17S for the detection of autoantibodies to nuclear antigens.
    Yi A; Lee CH; Moon HW; Kim H; Hur M; Yun YM
    Clin Biochem; 2018 May; 55():75-79. PubMed ID: 29608892
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Measurement of antinuclear antibodies and their fine specificities: time for a change in strategy?
    Otten HG; Brummelhuis WJ; Fritsch-Stork R; Leavis HL; Wisse BW; van Laar JM; Derksen RHWM
    Clin Exp Rheumatol; 2017; 35(3):462-470. PubMed ID: 28240588
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Basics in standardization and practical applications of immunofluorescent microscopy: standardization of antinuclear antibody tests.
    Beutner EH; Kumar V; Greenlee P
    Lab Res Methods Biol Med; 1983; 8():49-70. PubMed ID: 6358746
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Practical evaluation of methods for detection and specificity of autoantibodies to extractable nuclear antigens.
    Orton SM; Peace-Brewer A; Schmitz JL; Freeman K; Miller WC; Folds JD
    Clin Diagn Lab Immunol; 2004 Mar; 11(2):297-301. PubMed ID: 15013979
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of multiplexed fluorescent microsphere immunoassay for detection of autoantibodies to nuclear antigens.
    Martins TB; Burlingame R; von Mühlen CA; Jaskowski TD; Litwin CM; Hill HR
    Clin Diagn Lab Immunol; 2004 Nov; 11(6):1054-9. PubMed ID: 15539505
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical features of 39 patients with antibodies to extractable nuclear antigens despite negative antinuclear antibodies: evidence for autoimmunity including neurologic and connective tissue diseases.
    Davis JM; Moder KG; Homburger HA; Ytterberg SR
    Medicine (Baltimore); 2005 Jul; 84(4):208-217. PubMed ID: 16010205
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is high titre ANA specific for connective tissue disease?
    Vaile JH; Dyke L; Kherani R; Johnston C; Higgins T; Russell AS
    Clin Exp Rheumatol; 2000; 18(4):433-8. PubMed ID: 10949716
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An italian multicenter study for application of a diagnostic algorithm in autoantibody testing.
    Bonaguri C; Melegari A; Dall'Aglio P; Ballabio A; Terenziani P; Russo A; Battistelli L; Aloe R; Camisa R; Campaniello G; Sartori E; Monica C
    Ann N Y Acad Sci; 2009 Sep; 1173():124-9. PubMed ID: 19758140
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Antinuclear antibodies in systemic autoimmune disease].
    Rösken GHJ; van Beek AA; Bakker-Jonges LE; Schreurs MWJ
    Ned Tijdschr Geneeskd; 2020 Apr; 164():. PubMed ID: 32324347
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Staining of antinuclear antibodies and antibodies against removable nuclear antigens in connective tissue diseases.
    Oliva Menacho JE; Arroyo-Acevedo JL; Oliva-Candela JA; García-Hjarles MA; Domínguez-Huarcaya L
    Allergol Immunopathol (Madr); 2020; 48(1):18-25. PubMed ID: 31623944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.